The Estée Lauder Companies Inc.
NYSE-EL
Company Overview
The Estée Lauder Companies Inc. manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. The company offers a range of skin care products, including moisturizers, serums, cleansers, toners, body care, exfoliators, acne care and oil correctors, facial masks, cleansing devices, and sun care products; and makeup products, such as lipsticks, lip glosses, mascaras, foundations, eyeshadows, nail polishes, and powders, as well as compacts, brushes, and other makeup tools. It also provides fragrance products in various forms comprising eau de parfum sprays and colognes, as well as lotions, powders, creams, candles, and soaps; and hair care products that include shampoos, conditioners, styling products, treatment, finishing sprays, and hair color products, as well as sells ancillary products and services. The company offers its products under Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Smashbox, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, By Kilian, BECCA, Too Faced, Dr. Jart+, DECIEM, and The Ordinary brands. It also holds license arrangements for Tommy Hilfiger, Donna Karan New York, DKNY, Michael Kors, and Ermenegildo Zegna brands. The company sells its products through department stores, specialty-multi retailers, upscale perfumeries and pharmacies, and salons and spas; freestanding stores; its own and authorized retailer websites; third-party online malls; stores in airports; and in-flight and duty-free shops. The company was founded in 1946 and is headquartered in New York, New York.
Name
The Estée Lauder Companies Inc.
CEO
Mr. Fabrizio Freda
Website
www.elcompanies.com
Sector
Personal Care Products
Year Founded
1946
Profile
Market Cap
$30.2B
EV
$36.64B
Shares Out
358.72M
Revenue
$15.61B
Employees
48,050
Margins
Gross
71.67%
EBITDA
15.4%
Operating
10.12%
Pre-Tax
4.95%
Net
2.5%
FCF
9.23%
Returns (5Yr Avg)
ROA
8.17%
ROTA
59.99%
ROE
27.69%
ROCE
17.6%
ROIC
15.78%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$111.43
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$3,395M
Net Debt
$6,431M
Debt/Equity
1.85
EBIT/Interest
4.18
Growth (CAGR)
Rev 3Yr
-1.26%
Rev 5Yr
0.98%
Rev 10Yr
3.59%
Dil EPS 3Yr
-48.24%
Dil EPS 5Yr
-25.86%
Dil EPS 10Yr
-9.89%
Rev Fwd 2Yr
3.6%
EBITDA Fwd 2Yr
16.39%
EPS Fwd 2Yr
25.43%
EPS LT Growth Est
28.69%
Dividends
Yield
—
Payout
243.02%
DPS
$2.64
DPS Growth 3Yr
8.45%
DPS Growth 5Yr
9.59%
DPS Growth 10Yr
12.97%
DPS Growth Fwd 2Yr
9.09%